<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Dose-related <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood dyscrasias</z:e> during treatment with either <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> or <z:chebi fb="0" ids="32215">thiamphenicol</z:chebi> chiefly include erythroid suppression and may be recognized at an early stage by observation of <z:hpo ids='HP_0001896'>reticulocytopenia</z:hpo> and an <z:hpo ids='HP_0003452'>increased serum iron</z:hpo> concentration </plain></SENT>
<SENT sid="1" pm="."><plain>Ferrokinetic studies show the typical features of <z:hpo ids='HP_0001924'>sideroblastic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Whilst <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> is conjugated with <z:chebi fb="0" ids="24298">glucuronic acid</z:chebi> in the liver, <z:chebi fb="0" ids="32215">thiamphenicol</z:chebi> is predominantly eliminated by the kidney in its unmodified form </plain></SENT>
<SENT sid="3" pm="."><plain>Sensitization against both drugs has been described and may, following reexposure, lead to dangerous <z:hpo ids='HP_0001913'>granulocytopenia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Potentially the most dangerous late complication after <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> treatment, i.e. <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, has not thus far been observed in patients treated with <z:chebi fb="0" ids="32215">thiamphenicol</z:chebi> </plain></SENT>
</text></document>